The Google co-founder Sergey Brin on Thursday disclosed that he carried a mutation of a gene known as LRRK2 that gave him a higher-than-average risk of contracting Parkinson’s disease.
When I called medical experts and financial analysts for comment, the first question I got was: “Why would he disclose that?” They pointed out that since Mr. Brin was disease-free, might never get the disease, and even if he did get it, could probably function at a high level for many years, there was no need to inform shareholders or anyone else.
Mr. Brin declined to be interviewed. But my colleague Allen Salkin had some insights into one of Mr. Brin’s possible motives. Allen chatted with Mr. Brin at a New York party on Sept. 9 to promote 23andMe, the DNA-testing company of which Mr. Brin’s wife, Anne Wojcicki, is a co-founder. During their conversation, Mr. Brin said it could be useful to have one’s DNA code open to the public, where it could follow a sort of open-source model. If his data was public, he said, doctors — or anyone who was interested — could look at his results and make suggestions about how he should handle them, offering treatment suggestions if it showed he might be susceptible to a disease.
“I figure if I put it out there, people would look at it and I’d learn something I need to know sooner than if I hadn’t put it out there,” Mr. Brin told Allen. He also said he would soon start to blog about his DNA.
As of now, if Mr. Brin has received any advice, it is not widely known. The comments section of his blog remains empty.
Comments are no longer being accepted.